NASDAQ · Biotechnology

FBIO (FBIO) Stock

$2.67 -3.61% NASDAQ: FBIO Healthcare

Valuation

MetricValue
Price$2.67
Market Cap$88.69M
P/E Ratio0.91
P/B Ratio0.60
P/S Ratio1.48
EPS (TTM)$-0.07
52-Week High$4.53
52-Week Low$1.70
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE109.80%
ROA-13.00%
ROCE-111.11%
Gross Margin64.51%
Operating Margin-84.36%
Net Margin1.93%
Debt/Equity0.33
Current Ratio2.48

Annual Financials (USD)

Metric20212022202320242025
Revenue$69.0M$76.0M$85.0M$58.0M$63.0M
Operating Profit$-189.0M$-204.0M$-142.0M$-110.0M$-70.0M
Net Profit$-65.0M$-87.0M$-61.0M$-46.0M$7.0M
EPS$-11.85$-14.55$-8.47$-2.69$-0.07
Op Margin-274.1%-268.8%-168.4%-191.4%-111.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$397.0M$294.0M$168.0M$144.0M$186.0M
Total Liabilities$171.0M$244.0M$166.0M$146.0M$123.0M
Cash$306.0M$178.0M$81.0M$57.0M$79.0M
Borrowings$75.0M$127.0M$85.0M$76.0M$74.0M

Latest News

Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes Simply Wall St. · Jun 25, 2026 Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference GlobeNewswire · May 19, 2026 Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference GlobeNewswire · May 18, 2026 Fortress Biotech: Q1 Earnings Snapshot Associated Press · May 14, 2026 Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights GlobeNewswire · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-117.0M$-179.0M$-128.0M$-80.0M$-66.0M
Investing Cash Flow$24.0M$-26.0M$-10.0M$-30.0M$10.0M
Financing Cash Flow$-5.0M$-8.0M$-1.0M$0$-1.0M
Net Cash Flow$73.0M$-127.0M$-98.0M$-25.0M$22.0M
Free Cash Flow$-133.0M$-182.0M$-136.0M$-95.0M$-66.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.79
EV / EBITDA1.37
FCF Yield161.13%
Quick Ratio2.77
Interest Coverage-7.78
Return 1Y90.31%
Return 3Y-52.18%
Return 5Y-92.13%

Ownership

Insiders Held22.79%
Institutions Held24.76%
Institutions Float Held32.07%
Institutional HolderSharesReport Date
Opaleye Management Inc.1,042,0002026-03-31
Vanguard Capital Management LLC966,0302026-03-31
Shikiar Asset Management, Inc.305,4692026-03-31
Geode Capital Management, LLC290,2552026-03-31
GSA Capital Partners LLP254,1342026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADAGAdagene Inc. $3.67 +1.66% -7.78 $138.17M 0.00%
CRVO $2.56 -3.76% -1.09 $23.70M 0.00%
GANX $1.73 -6.99% -2.70 $73.79M 0.00%
IMUXImmunic, Inc. $13.81 +3.14% -2.24 $188.11M 0.00%
NTRB $3.11 +6.69% -1.40 $37.81M 0.00%

About FBIO

FBIO is led by CEO Lindsay Allan Rosenwald, employs 101 people, headquartered in US, publicly traded since 2011.

FBIO stock trades at $2.67 with a market capitalization of $88.69M. The stock is valued at a price-to-earnings (P/E) ratio of 0.91, price-to-book of 0.60, price-to-sales of 1.48. Over the past 52 weeks the stock has ranged between $1.70 and $4.53, and currently trades 41.1% below its 52-week high.

On profitability, FBIO generates a return on equity (ROE) of 109.80% — well above the market average, a sign of a high-quality business, return on capital employed of -111.11%, an operating margin of -84.36%, a net profit margin of 1.93%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides